C4 Therapeutics CCCC
NASDAQ CCCC
$3.17 +0.01 (+0.32%)
At close: Oct 21, 2026 · 4:00 PM EDT

C4 Therapeutics (CCCC) Preferred Dividend Payments (2020)

Updated

C4 Therapeutics' Preferred Dividend Payments was $5.21 million in Q3 2020, up 79.2% from the prior quarter.

Analysis

C4 Therapeutics (CCCC) Preferred Dividend Payments (2020) Analysis & Trends

For FY2019, Preferred Dividend Payments at C4 Therapeutics came in at $8.47 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Pref Dividends (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn -
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn -
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn -
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 C4 Therapeutics 413.66 Mn -516.10 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2020 5.21 Mn
Jun 30, 2020 2.91 Mn
Mar 31, 2020 2.11 Mn
API Access

C4 Therapeutics Preferred Dividend Payments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-dividend-payments&ticker=CCCC&period=max&api_key=YOUR_API_KEY